Cargando…
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries
Autores principales: | Hernandez, Inmaculada, Tadrous, Mina, Magnani, Jared W., Guo, Jingchuan, Suda, Katie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994109/ https://www.ncbi.nlm.nih.gov/pubmed/33768423 http://dx.doi.org/10.1007/s40256-021-00475-9 |
Ejemplares similares
-
Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysis
por: Hernandez, Inmaculada, et al.
Publicado: (2022) -
COVID‐19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data
por: Hernandez, Inmaculada, et al.
Publicado: (2021) -
Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis
por: Zeitouny, Seraphine, et al.
Publicado: (2021) -
Effects of the July 2018 worldwide valsartan recall and shortage on global trends in antihypertensive medication use: a time-series analysis in 83 countries
por: Choi, Yuna, et al.
Publicado: (2023) -
Global trends in antidepressant, atypical antipsychotic, and benzodiazepine use: A cross-sectional analysis of 64 countries
por: Alabaku, Orges, et al.
Publicado: (2023)